Neurocrine Biosciences (NBIX) Return on Capital Employed [ROCE] (2011 - 2026)
Neurocrine Biosciences' Return on Capital Employed [ROCE] came in at 18.67% for Q2 2026, up 3.40 percentage points from 15.27% a year earlier but down 1.37 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Neurocrine Biosciences' Return on Capital Employed [ROCE] was 18.04%, down 1.12 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of +5.82 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was 19.16% in FY2024 (+7.52 pp), 11.64% in FY2023 (-3.15 pp), 14.80% in FY2022 (+8.61 pp) and 6.18% in FY2021 (-6.04 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is 3.69% (Q2 2022) to 20.04% (Q1 2026).
- Year-over-year, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of +1.93 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2024 (a gain of 10.91 percentage points), and the weakest in Q4 2021 (a drop of 5.68 percentage points).
- Business Quant data shows NBIX's Return on Capital Employed [ROCE] at 20.04% (Q1 2026), 16.71% (Q4 2025) and 16.00% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 18.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.67% |
| Mar 31, 2026 | 20.04% |
| Dec 31, 2025 | 16.71% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | 15.27% |
| Mar 31, 2025 | 15.56% |
| Dec 31, 2024 | 18.29% |
| Sep 30, 2024 | 19.36% |
| Jun 30, 2024 | 17.93% |
| Mar 31, 2024 | 17.53% |
| Dec 31, 2023 | 10.48% |
| Sep 30, 2023 | 10.00% |
| Jun 30, 2023 | 7.91% |
| Mar 31, 2023 | 6.62% |
| Dec 31, 2022 | 14.49% |
| Sep 30, 2022 | 6.88% |
| Jun 30, 2022 | 3.69% |
| Mar 31, 2022 | 3.99% |
| Dec 31, 2021 | 5.70% |
| Sep 30, 2021 | 11.96% |
API Access
Neurocrine Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();